Achieve Life Sciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.9% | -73.0% | +137.3% | -96.6% | +2,042.1% | -99.7% | +0.0% | +1,059,748.0% | -96.9% | +171.3% | -10.1% | +0.0% | +26.9% | -46.7% | -59.6% | +265.6% | +48.7% | -9.3% | -33.0% | -72.1% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +41.5% | +71.6% | -14.6% | +40.0% | +128.7% | -67.5% | -48.1% | +88.9% | +158.4% | -8.6% | +16.6% | +85.4% | -100.0% | – | – | – | – | +0.0% | -9.9% | +0.4% | -2.0% | -5.6% | -3.4% | +0.4% | -0.4% | |
| – | +14.0% | -69.7% | +115.3% | -125.8% | – | -99.3% | +0.0% | +1,059,748.0% | -96.9% | +171.3% | -10.1% | +0.0% | +26.9% | -46.7% | -59.6% | +265.6% | +48.7% | -9.3% | -33.0% | -72.1% | -105.6% | – | – | – | – | – | – | – | – | |
| – | +3.6% | -9.5% | -46.7% | -41.8% | +60.2% | +71.5% | -14.6% | +39.9% | +128.8% | +67.8% | -34.0% | -71.2% | +209.0% | -23.5% | +16.6% | +85.3% | +38.5% | -16.4% | -45.7% | -41.1% | -79.0% | +89.2% | +64.9% | -28.9% | +248.2% | +25.5% | -47.4% | +44.3% | +0.6% | |
| – | +89.0% | -9.0% | -11.8% | -31.7% | -16.2% | +97,856.0% | -7.2% | +95.0% | -5.1% | +36.0% | +8.5% | -100.0% | +20.3% | +47.4% | +6.7% | +25.1% | +27.0% | +7.4% | +11.1% | -24.3% | -60.5% | +96.7% | -1.3% | +14.8% | +16.0% | +17.5% | +6.7% | +42.1% | +96.1% | |
| – | +25.2% | -8.2% | -28.7% | -39.8% | +11.7% | +43.0% | -12.6% | +55.4% | +81.4% | +61.9% | -27.3% | -68.6% | +153.1% | -13.5% | +14.2% | +71.8% | +36.6% | -12.8% | -35.1% | -35.7% | -72.0% | +93.2% | +29.0% | -12.3% | +128.3% | +23.3% | -33.2% | +42.5% | +40.7% | |
| – | -93.8% | -12,000.0% | – | -903.6% | – | -5,727.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +385.0% | -79.4% | +135.0% | -92.8% | -59.3% | +128.5% | +33.1% | -41.6% | -72.3% | -56.3% | -85.5% | -100.0% | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | -75.4% | +10,423.5% | +59.5% | -23.6% | -62.4% | |
| – | -50.0% | -1,115.5% | – | -640.6% | – | -1,681.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.0% | -830.0% | – | -137.6% | – | -150.7% | – | – | – | – | – | – | – | -199.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -41.2% | -1,220.0% | – | -636.9% | – | -2,246.1% | – | – | – | – | – | – | – | -329.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -66.7% | -1,683.0% | – | -1,987.1% | – | -2,543.6% | – | – | – | – | – | – | – | -1,194.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.